The American Medical Association urges greater transparency and oversight for imaging AI to maximize trust and patient safety.
Key Details
- 1AMA passed a resolution advocating for explainable AI tools in radiology and other fields.
- 2The association calls for third-party oversight of AI algorithms rather than relying solely on vendor claims.
- 3AMA emphasizes the need for detailed explanations of AI outputs, especially given potential 'life or death consequences.'
- 4Intellectual property concerns should not outweigh the need for explainable AI in medicine.
- 5Lack of explainability may put physicians in difficult positions and undermine their clinical judgment.
Why It Matters
The AMA's stance highlights the critical need for trustworthy AI tools in radiology, impacting both provider decision-making and patient care. Increased transparency and oversight may shape future AI regulations, adoption, and industry practices.
Source
Radiology Business
Related News
•AuntMinnie
United Healthcare Adds Coverage for Elucid's PlaqueIQ AI Platform
United Healthcare will begin covering Elucid's PlaqueIQ coronary CTA plaque quantification AI software starting October 1.
•AI in Healthcare
AMA Responds to AI Policy, Illinois Bans AI Therapy, Mayo Clinic Expands AI Initiatives
Key national and institutional developments shape the future of AI in healthcare and radiology.
•AI in Healthcare
White House AI Action Plan and Emerging Trends in Healthcare Imaging AI
The White House AI Action Plan, evolving GenAI monetization models, and AI governance challenges shape current healthcare AI debates.